0000950123-20-004648.txt : 20200513
0000950123-20-004648.hdr.sgml : 20200513
20200513121639
ACCESSION NUMBER: 0000950123-20-004648
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200331
FILED AS OF DATE: 20200513
DATE AS OF CHANGE: 20200513
EFFECTIVENESS DATE: 20200513
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MPM Oncology Impact Management LP
CENTRAL INDEX KEY: 0001687078
IRS NUMBER: 364818254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20107
FILM NUMBER: 20871865
BUSINESS ADDRESS:
STREET 1: 450 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 6174259200
MAIL ADDRESS:
STREET 1: 450 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001687078
XXXXXXXX
03-31-2020
03-31-2020
MPM ONCOLOGY IMPACT MANAGEMENT LP
450 KENDALL STREET
CAMBRIDGE
MA
02142
13F HOLDINGS REPORT
028-20107
N
Ansbert Gadicke
Member
(617) 425-9200
/s/ Ansbert Gadicke
Cambridge
MA
05-12-2020
0
10
163704
false
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
Autolus Therapeutics Limited
Common
05280R100
238
39740
SH
SOLE
39740
0
0
CytomX Therapeutics, Inc.
Common
23284F105
6561
855437
SH
SOLE
855437
0
0
Epizyme, Inc.
Common
29428V104
36162
2331534
SH
SOLE
2331534
0
0
G1 Therapeutics, Inc.
Common
3621LQ109
15690
1423794
SH
SOLE
1423794
0
0
Harpoon Therapeutics, Inc.
Common
41358P106
45144
3898422
SH
SOLE
3898422
0
0
MEI Pharma, Inc.
Common
552798202
10063
6250000
SH
SOLE
6250000
0
0
Sunesis Pharmaceuticals, Inc.
Common
867328700
1166
2809912
SH
SOLE
2809912
0
0
TCR2 Therapeutics, Inc.
Common
87808K106
26091
3370982
SH
SOLE
3370982
0
0
Turning Point Therapeutics, Inc.
Common
90041T108
13786
308686
SH
SOLE
308686
0
0
YmAbs Therapeutics, Inc.
Common
984241109
8803
337291
SH
SOLE
337291
0
0